======= IKZF3 ======= == Gene Information == * **Official Symbol**: IKZF3 * **Official Name**: IKAROS family zinc finger 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22806|22806]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UKT9|Q9UKT9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IKZF3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IKZF3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606221|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the Ikaros family of zinc-finger proteins. Three members of this protein family (Ikaros, Aiolos and Helios) are hematopoietic-specific transcription factors involved in the regulation of lymphocyte development. This gene product is a transcription factor that is important in the regulation of B lymphocyte proliferation and differentiation. Both Ikaros and Aiolos can participate in chromatin remodeling. Regulation of gene expression in B lymphocytes by Aiolos is complex as it appears to require the sequential formation of Ikaros homodimers, Ikaros/Aiolos heterodimers, and Aiolos homodimers. Several alternative transcripts encoding different isoforms have been described, as well as some non-protein coding variants. [provided by RefSeq, Apr 2012]. * **UniProt Summary**: N/A |zf-C2H2| |regulation of B cell differentiation| |regulation of B cell proliferation| |mesoderm development| |B cell activation| |regulation of lymphocyte differentiation| |regulation of B cell activation| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |transcription regulatory region DNA binding| |regulation of leukocyte proliferation| |regulation of leukocyte differentiation| |RNA polymerase II regulatory region sequence-specific DNA binding| |lymphocyte activation| |sequence-specific DNA binding| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |protein heterodimerization activity| |regulation of lymphocyte activation| |regulation of leukocyte activation| |regulation of cell activation| |DNA-binding transcription factor activity| |response to bacterium| |protein homodimerization activity| |leukocyte activation| |identical protein binding| |cell activation| |positive regulation of transcription by RNA polymerase II| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |regulation of cell death| |positive regulation of RNA metabolic process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.81| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-1.71| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.73| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.89| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13823 * **Expression level (log2 read counts)**: 5.46 {{:chemogenomics:nalm6 dist.png?nolink |}}